Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

36 filings reported holding ACHL - Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share as of Q2 2021.
Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,784,784 shares of 41,123,390 outstanding shares and own 45.68% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5,014,687 shares), BAKER BROS. ADVISORS LP (2,591,366 shares), Artal Group S.A. (2,255,375 shares), Redmile Group, LLC (2,088,089 shares), ORBIMED ADVISORS LLC (1,584,845 shares), BOXER CAPITAL, LLC (1,536,016 shares), Farallon Capital Management LLC (996,540 shares), PERCEPTIVE ADVISORS LLC (755,375 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (301,431 shares), and SPHERA FUNDS MANAGEMENT LTD. (292,194 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.